Evidence map›Paper›PMID 24288682›Full record

ArticleBioMed research international2013

5-lipoxygenase deficiency reduces acetaminophen-induced hepatotoxicity and lethality.

Miriam S N Hohmann, Renato D R Cardoso, Felipe A Pinho-Ribeiro, Jefferson Crespigio, Thiago M Cunha, José C Alves-Filho, Rosiane V da Silva, Phileno Pinge-Filho, Sergio H Ferreira, Fernando Q Cunha and 2 more

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
7.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Therapeutic activity of lipoxin AFrontiers in immunology · 2023
    Article
  5. Article
  6. Review
  7. Article
  8. Methyl gallate attenuates inflammation induced by Toll-like receptor ligands by inhibiting MAPK and NF-Κb signaling pathways.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2020
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Naringenin mitigates titanium dioxide (TiOInflammation research : official journal of the European Histamine Research Society ... [et al.] · 2018
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Miriam S N HohmannDepartment of Pathology, Biological Science Centre, State University of Londrina, Rodovia Celso Garcia Cid Pr 445, Km 380. Cx. Postal 6001, 86051-990 Londrina PR, Brazil.
Renato D R Cardoso
Felipe A Pinho-Ribeiro
Jefferson Crespigio
Thiago M Cunha
José C Alves-Filho
Rosiane V da Silva
Phileno Pinge-Filho
Sergio H Ferreira
Fernando Q Cunha
Rubia Casagrande
Waldiceu A Verri
Universidade Estadual de Londrina · BRUniversidade de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

5-Lipoxygenase (5-LO) converts arachidonic acid into leukotrienes (LTs) and is involved in inflammation. At present, the participation of 5-LO in acetaminophen (APAP)-induced hepatotoxicity and liver damage has not been addressed. 5-LO deficient (5-LO⁻/⁻) mice and background wild type mice were challenged with APAP (0.3-6 g/kg) or saline. The lethality, liver damage, neutrophil and macrophage recruitment, LTB₄, cytokine production, and oxidative stress were assessed. APAP induced a dose-dependent mortality, and the dose of 3 g/kg was selected for next experiments. APAP induced LTB4 production in the liver, the primary target organ in APAP toxicity. Histopathological analysis revealed that 5-LO⁻/⁻ mice presented reduced APAP-induced liver necrosis and inflammation compared with WT mice. APAP-induced lethality, increase of plasma levels of aspartate aminotransferase and alanine aminotransferase, liver cytokine (IL-1β, TNF-α , IFN- γ, and IL-10), superoxide anion, and thiobarbituric acid reactive substances production, myeloperoxidase and N-acetyl-β-D-glucosaminidase activity, Nrf2 and gp91(phox) mRNA expression, and decrease of reduced glutathione and antioxidant capacity measured by 2,2'-azinobis(3-ethylbenzothiazoline 6-sulfonate) assay were prevented in 5-LO⁻/⁻ mice compared to WT mice. Therefore, 5-LO deficiency resulted in reduced mortality due to reduced liver inflammatory and oxidative damage, suggesting 5-LO is a promising target to reduce APAP-induced lethality and liver inflammatory/oxidative damage.

Indexed as

Arachidonate 5-LipoxygenaseAcetaminophenAlanine TransaminaseAnalgesics, Non-NarcoticAnimalsChemical and Drug Induced Liver InjuryCytokinesInflammationMembrane GlycoproteinsMiceMice, KnockoutNADPH Oxidase 2NADPH OxidasesNF-E2-Related Factor 2Oxidation-ReductionSuperoxidesAcetaminophenAlanine TransaminaseAnalgesics, Non-NarcoticArachidonate 5-LipoxygenaseCybb protein, mouseCytokinesMembrane GlycoproteinsNADPH Oxidase 2NADPH OxidasesNfe2l2 protein, mouseNF-E2-Related Factor 2Superoxides

Identifiers

PMID24288682
PMCPMC3832964
OpenAlexW2041354200

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.